Neutral sphingomyelinase (SMPD3) deficiency disrupts the Golgi secretory pathway and causes growth inhibition. [electronic resource]
Producer: 20170828Description: e2488 p. digitalISSN:- 2041-4889
- Animals
- Apoptosis -- drug effects
- Cell Proliferation -- drug effects
- Cells, Cultured
- Ceramides -- metabolism
- Chondrocytes -- drug effects
- Detergents -- pharmacology
- Diglycerides -- metabolism
- Endoplasmic Reticulum Stress -- drug effects
- Gene Expression Profiling
- Golgi Apparatus -- drug effects
- HEK293 Cells
- Homeostasis -- drug effects
- Humans
- Membrane Microdomains -- drug effects
- Mice, Inbred C57BL
- Secretory Pathway -- drug effects
- Solubility
- Sphingomyelin Phosphodiesterase -- deficiency
- Sphingomyelins -- metabolism
- Transferases (Other Substituted Phosphate Groups) -- metabolism
- Type C Phospholipases -- metabolism
- Unfolded Protein Response -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.